Post-Exposure Syndromes as State-Space Trapping: A Set-Theoretic Perspective on PSSD and the Post-Exposure Family

April 2026 in “ Zenodo (CERN European Organization for Nuclear Research) ”

Antonei B. Csòka

New to Finasteride? There is a guide in the encyclopedia. Read the guide →

Post-SSRI Sexual Dysfunction PSSD post-finasteride syndrome finasteride Long COVID ME/CFS PTSD Gulf War illness chronic multisystem symptoms pharmacovigilance adverse-event reporting surveillance cohorts informed-consent language

Preprint — not peer reviewed. This was posted to a preprint server or data repository. It has not been through a journal's review process, and its findings may change or not hold up.

Studysummary This presentation argues that post-exposure syndromes like PSSD and Long COVID form a coherent group of conditions driven by complex interactions in high-dimensional state spaces rather than singular molecular pathways.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

View this study on zenodo.org →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Post-Exposure Syndromes as State-Space Trapping: A set-theoretic perspective on PSSD and the post-exposure family.

April 2026 in “Zenodo (CERN European Organization for Nuclear Research)”

This study examines how conditions like PSSD, Long COVID, and ME/CFS form a "Post-Exposure Syndromes" family, initiated by transient exposures but persisting due to complex state-space dynamics, and suggests improving pharmacovigilance to better address and understand these persistent syndromes.

research Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?

40 citations , April 2018 in “Endocrine”

This review discusses post-SSRI sexual dysfunction and post-finasteride syndrome, highlighting unknowns about their true incidence and underlying causes, and reports no new clinical results.

Post-Finasteride Syndrome and Post-SSRI Sexual Dysfunction: Two Clinically Similar Conditions

research POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE

November 2023 in “Frontiers in Neuroendocrinology”

This study suggests that post-finasteride syndrome and post-SSRI sexual dysfunction share potential etiopathogenetic mechanisms involving brain modulators, neurotransmitters, and gut microbiota, although more research is needed to understand these conditions fully.

research Post-Drug Syndromes: A Neglected Challenge in Pharmacovigilance and Public Health

December 2025 in “Zenodo (CERN European Organization for Nuclear Research)”

This policy brief reports that post-drug syndromes like Post-Finasteride Syndrome are largely overlooked in current pharmacovigilance systems, which prioritize acute drug reactions, resulting in inadequate recognition and management of persistent medication-induced conditions.

research PSSD,PFS,PRSD: A perspective for aetiology and treatment

April 2023

This paper introduces a framework attributing Post-SSRI, Post-Finasteride, Post-Retinoid, and an unnamed sexual dysfunction syndrome to downregulated estrogen receptor activity, potentially guiding future treatments in sexual medicine.